| Market Cap | ₹665Cr |
| ROE | 19.63% |
| P/E Ratio(TTM) | 28.26 |
| EPS(TTM) | 9.62 |
| P/B Ratio | 5.42 |
| Dividend Yield | 0.00% |
| Industry P/E | 55.77 |
| Book Value | 50.14 |
| Debt to Equity | 0.48 |
| Face Value | 10 |
| Managing Director | Chandan Singh |
| Founded | 2005 |
| NSE Symbol | CHANDAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 45.36 | ||
| Metropolis Healthcare | NA (0.00%) | 60.70 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 65.31 | ||
| Thyrocare Technologies | NA (0.00%) | 47.73 |